"Decoding the Chemistry Behind Alzheimer’s Disease Therapies"
Speaker: Michael R. Nichols, Ph.D. Professor, Department of Chemistry & Biochemistry, Director of the biochemistry and biotechnology program, University of Missouri-St. Louis, President of the American Society for Neurochemistry
Date: Tuesday August 14, 2024, noon-1 p.m.
Location: UMSL Millennium Student Center, The Chamber
*Zoom option available
Register Here
About the Speaker
Dr. Michael Nichols received his B.S. degree from Lindenwood College and Ph.D. from Purdue University. Prior to joining UMSL in Fall 2004, he completed a postdoctoral fellowship at the Mayo Clinic in Jacksonville, FL. He was appointed Associate Chair in 2019. Currently he is serving as the President of the American Society for Neurochemistry. His research area involves mechanistic studies of Aβ aggregation and the question of how Aβ aggregates are detrimental to cells. He heads a NIH funded laboratory ‘Mechanisms of NLRP3 inflammasome activation” that is focused on understanding how different signals trigger the NLRP3 activation which can lead to new therapeutic strategies for inflammatory, neurodegenerative, and heart diseases.
The Discovery Series
The NextGen Precision Health Discovery Series provides learning opportunities for UM System faculty and staff across disciplines, the statewide community and our other partners to learn about the scope of precision health research and identify potential collaborative opportunities. The series consists of monthly lectures geared toward a broad multidisciplinary audience so all can participate and appreciate the spectrum of precision health efforts.
Information about this upcoming talk, including continuing education, is available below.
For questions about this event or any others in the Discovery Series, please reach out to Veronica Lemme at lemmev@health.missouri.edu.
Reviewed 2024-06-06